Top cancer expert labels NHS delay over ground-breaking treatment a ‘scandal’

Professor Michael Baum first worked on the treatment for tackling breast cancer, known as TARGIT IORT, 20 years ago at University College London with colleagues Dr Jeffrey Tobias and Dr Jayant Vaidya. It has been available almost exclusively to private patients but only now has NICE, the National Institute for Health and Care Excellence, approved funding for its use in the NHS. “It is a scandal that NHS patients have been denied this treatment when it has become the standard of care in Germany, Australia and many other countries,” said Prof Baum, who is now emeritus professor of surgery at UCL and is a world expert on breast cancer.